Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wilding

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Cancer Chemotherapy and Pharmacology|January 22, 2002
Phase I clinical and pharmacokinetic trial of irofulvenJ P Thomas, R Arzoomanian, D Alberti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancerH I Robins, K Tutsch, D M Katschinski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a dayG H Ripple, M N Gould, R Z Arzoomanian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignanciesL Ochoa, H I Hurwitz, G Wilding, et al.
The New England Journal of Medicine|October 8, 1998
Bilateral orchiectomy with or without flutamide for metastatic prostate cancerM A Eisenberger, B A Blumenstein, E D Crawford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2011
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trialA J Zurita, D J George, N D Shore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patientsH I Robins, D Rushing, M Kutz, et al.
Cancer Chemotherapy and Pharmacology|April 1, 1999
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermiaH I Robins, D M Katschinski, W Longo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2010
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumorsD J Jonker, L S Rosen, M B Sawyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupG J Bubley, M Carducci, W Dahut, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|January 22, 2002
Phase I clinical and pharmacokinetic trial of irofulvenJ P Thomas, R Arzoomanian, D Alberti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancerH I Robins, K Tutsch, D M Katschinski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a dayG H Ripple, M N Gould, R Z Arzoomanian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignanciesL Ochoa, H I Hurwitz, G Wilding, et al.
The New England Journal of Medicine|October 8, 1998
Bilateral orchiectomy with or without flutamide for metastatic prostate cancerM A Eisenberger, B A Blumenstein, E D Crawford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2011
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trialA J Zurita, D J George, N D Shore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patientsH I Robins, D Rushing, M Kutz, et al.
Cancer Chemotherapy and Pharmacology|April 1, 1999
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermiaH I Robins, D M Katschinski, W Longo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2010
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumorsD J Jonker, L S Rosen, M B Sawyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupG J Bubley, M Carducci, W Dahut, et al.
Pageof 11